Target intelligence / Profile preview

16S ribosomal RNA (16S rRNA) (16S rRNA)

Target
16S rRNA
Molecular classification
Ribosomal RNA, Ribonucleoprotein component
01

Overview

The 16S ribosomal RNA (16S rRNA) is a fundamental structural and functional component of the 30S small ribosomal subunit in prokaryotes, essential for the initiation and accuracy of protein synthesis (UniProt). It plays a vital role in decoding messenger RNA (mRNA) by facilitating the correct pairing of transfer RNA (tRNA) anticodons with mRNA codons at the ribosomal A-site (PubMed, PMID: 11130704). Aminoglycoside antibiotics, including Gentamicin, Amikacin, and G418 (Geneticin), exert their antimicrobial effects by binding specifically to the internal loop of helix 44 within the 16S rRNA (PubChem). This interaction stabilizes a specific conformation of adenine residues that normally signals correct codon-anticodon recognition, thereby forcing the ribosome to accept incorrect tRNAs and leading to the synthesis of mistranslated or truncated proteins (StatPearls). While primarily targeting bacterial ribosomes, certain aminoglycosides like G418 also exhibit activity against eukaryotic 80S ribosomes, making them useful selection agents in laboratory settings but also contributing to potential toxicity in human cells (Sigma-Aldrich). Clinical use of these drugs is often limited by significant safety concerns, including permanent ototoxicity and reversible nephrotoxicity, which require careful therapeutic drug monitoring (NIH, LiverTox). Furthermore, the emergence of resistance through 16S rRNA methyltransferases or aminoglycoside-modifying enzymes remains a major challenge in treating infections (PubMed, PMID: 28438943).

Other names
30S ribosomal subunitSmall ribosomal subunit RNA18S ribosomal RNA (eukaryotic equivalent)Geneticin target
02

Mechanism of action

Aminoglycosides bind to the A-site of the 16S ribosomal RNA, inducing conformational changes that lead to mRNA misreading and inhibition of translocation.

03

Biological functions

Protein synthesisTranslationmRNA decoding
04

Disease associations

InfectionBacterial infectionGenetic disorders (nonsense mutation suppression)
05

Safety considerations

Ototoxicity (vestibular and cochlear)Nephrotoxicity (acute kidney injury)Neuromuscular blockade
06

Interacting drugs

G418 (Geneticin)

7 more in the full profile.

07

Biomarkers

Aminoglycoside-modifying enzymes (AMEs)16S rRNA methyltransferases (e.g., ArmA, RmtA)Serum creatinine (toxicity monitoring)Audiometry (toxicity monitoring)

Beyond the preview

Go deeper on 16S ribosomal RNA (16S rRNA) (16S rRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 16S ribosomal RNA (16S rRNA) (16S rRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call